The effect of gabapentin supplementation in ureteral stone patients
Phase 3
Recruiting
- Conditions
- ureteral stone disease.Presence of urogenital implantsZ96.0
- Registration Number
- IRCT20170417033489N8
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Patients with unilateral ureteral stones more than 15 mm in diameter who have undergone TUL lithotripsy
Patients should be over 18 years old
A double G catheter is installed for them
Exclusion Criteria
Chronic use (more than 3 months) of alpha-blocker and analgesic drugs
History of neurogenic bladder
Recurrent urinary tract infections
Chronic pelvic pain
Patient dissatisfaction
Leaving the study during the study process
People who are contraindicated in gabapentin
History of previous allergy to gabapentin
Pregnancy
Breastfeeding
Liver failure
Renal failure
People who are in the high-risk group due to the drowsiness complication of the drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score obtained based on the patient's irritating symptoms questionnaire. Timepoint: Before intervention and 14 days after gabapentin. Method of measurement: ureteral stent symptom questionnaire (USSQ).
- Secondary Outcome Measures
Name Time Method